News Image

Looking for growth without the hefty price tag? Consider CORCEPT THERAPEUTICS INC (NASDAQ:CORT).

By Mill Chart

Last update: May 10, 2025

Discover CORCEPT THERAPEUTICS INC (NASDAQ:CORT), an undervalued growth gem identified by our stock screener. CORT is shining in terms of growth metrics, and it's also displaying strong financial health and profitability. What's more, it retains an appealing valuation. We'll break it down further.


Affordable growth stocks image

Assessing Growth for CORT

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. CORT has received a 9 out of 10:

  • The Earnings Per Share has grown by an nice 9.43% over the past year.
  • The Earnings Per Share has been growing by 9.71% on average over the past years. This is quite good.
  • The Revenue has grown by 39.94% in the past year. This is a very strong growth!
  • Measured over the past years, CORT shows a quite strong growth in Revenue. The Revenue has been growing by 17.11% on average per year.
  • Based on estimates for the next years, CORT will show a very strong growth in Earnings Per Share. The EPS will grow by 54.37% on average per year.
  • Based on estimates for the next years, CORT will show a very strong growth in Revenue. The Revenue will grow by 29.15% on average per year.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

A Closer Look at Valuation for CORT

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. CORT has achieved a 5 out of 10:

  • Compared to the rest of the industry, the Price/Earnings ratio of CORT indicates a somewhat cheap valuation: CORT is cheaper than 78.28% of the companies listed in the same industry.
  • Based on the Price/Forward Earnings ratio, CORT is valued a bit cheaper than 78.28% of the companies in the same industry.
  • CORT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CORT is cheaper than 75.25% of the companies in the same industry.
  • 79.29% of the companies in the same industry are more expensive than CORT, based on the Price/Free Cash Flow ratio.
  • CORT has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CORT's earnings are expected to grow with 71.20% in the coming years.

What does the Health looks like for CORT

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For CORT, the assigned 8 for health provides valuable insights:

  • An Altman-Z score of 30.93 indicates that CORT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 30.93, CORT belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
  • CORT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 3.35 indicates that CORT has no problem at all paying its short term obligations.
  • A Quick Ratio of 3.26 indicates that CORT has no problem at all paying its short term obligations.

Assessing Profitability for CORT

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. CORT has earned a 7 out of 10:

  • CORT has a Return On Assets of 16.80%. This is amongst the best in the industry. CORT outperforms 96.97% of its industry peers.
  • The Return On Equity of CORT (20.78%) is better than 91.41% of its industry peers.
  • CORT's Return On Invested Capital of 16.89% is amongst the best of the industry. CORT outperforms 92.42% of its industry peers.
  • Looking at the Profit Margin, with a value of 20.92%, CORT belongs to the top of the industry, outperforming 92.93% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 20.29%, CORT belongs to the top of the industry, outperforming 85.86% of the companies in the same industry.
  • CORT's Gross Margin of 98.39% is amongst the best of the industry. CORT outperforms 97.47% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of CORT contains the most current fundamental analsysis.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (5/9/2025, 8:00:01 PM)

After market: 70.23 0 (0%)

70.23

-1.15 (-1.61%)



Find more stocks in the Stock Screener

CORT Latest News and Analysis

ChartMill News Image5 minutes ago - ChartmillLooking for growth without the hefty price tag? Consider CORCEPT THERAPEUTICS INC (NASDAQ:CORT).

Uncover the potential of CORCEPT THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:CORT is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.

ChartMill News Image2 days ago - ChartmillWill CORCEPT THERAPEUTICS INC (NASDAQ:CORT) breakout?

Exploring CORCEPT THERAPEUTICS INC's Technical Signals and Breakout Potential: Indications Suggest NASDAQ:CORT Could Be on the Verge of a Breakout.

ChartMill News Image5 days ago - ChartmillTop movers in Monday's after hours session

Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.

Mentions: NBIX MRIN OGEN AMRC ...

ChartMill News Image10 days ago - ChartmillCORCEPT THERAPEUTICS INC (NASDAQ:CORT), a strong growth stock, setting up for a breakout.

Based on a technical and fundamental analysis of NASDAQ:CORT we ask: Is CORCEPT THERAPEUTICS INC (NASDAQ:CORT) on the Verge of a Major Breakout as a Strong Growth Stock?

Follow ChartMill for more